Medicare Limits Coverage of Controversial Alzheimer’s Drug to Those in Clinical Trials
April 8th, 2022 by Global Down Syndrome Foundation
For People With Down Syndrome, A Longer Life, But Under A Cloud
April 7th, 2022 by Global Down Syndrome Foundation
For People With Down Syndrome, A Longer Life, But Under A Cloud
The Washington Post | Apr 07, 2022
More Lawmakers Ratchet Up Pressure on CMS to Overturn Aduhelm Coverage Proposal
April 4th, 2022 by Global Down Syndrome Foundation
More Lawmakers Ratchet Up Pressure on CMS to Overturn Aduhelm Coverage Proposal
Fierce Healthcare | Apr 04, 2022
National Coverage Determination May Limit Access to AD Treatment
March 14th, 2022 by Global Down Syndrome Foundation
National Coverage Determination May Limit Access to AD Treatment
HealthPayerIntelligence | Mar 14, 2022
Medicare Proposal on Alzheimer’s Drug Draws Criticism From Drugmakers
February 23rd, 2022 by Global Down Syndrome Foundation
Medicare Proposal on Alzheimer’s Drug Draws Criticism From Drugmakers
The Wall Street Journal | Feb 23, 2022
Alzheimer’s patients ‘devastated’ at Medicare limits on drug critics say needs more testing
February 18th, 2022 by Wes Butler
Alzheimer’s patients ‘devastated’ at Medicare limits on drug critics say needs more testing
USA Today | Feb 18, 2022
How The Medical System Is Failing People With Down Syndrome And Alzheimer’s Disease
February 10th, 2022 by Wes Butler
How The Medical System Is Failing People With Down Syndrome And Alzheimer’s Disease
Forbes | Feb 10, 2022
CMS severely limits coverage of Alzheimer’s treatment: What it means for people living with the disease
January 24th, 2022 by Wes Butler
CMS severely limits coverage of Alzheimer’s treatment: What it means for people living with the disease
WFMY News 2 | Jan 24, 2022
Biogen Alzheimer’s Drug Coverage Threatens Minorities’ Access
January 13th, 2022 by Global Down Syndrome Foundation
Biogen Alzheimer’s Drug Coverage Threatens Minorities’ Access
Bloomberg Law | Jan 13, 2022
Medicare limits coverage of $28,000-a-year Alzheimer’s drug
January 12th, 2022 by Global Down Syndrome Foundation
Medicare limits coverage of $28,000-a-year Alzheimer’s drug
FOX 59 | Jan 12, 2022
Experience our inspirational and groundbreaking videos and photos. Our children and self-advocates are beautiful AND brilliant!
Make sure your local Representatives are on the Congressional Down Syndrome Task Force.
Keep up with research news, upcoming programs, events and educational conferences.
Find us online here: